uromigos live 2023: dr. alan tan on survival benefit in psmafore
Published 1 year ago • 245 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
2:44
uromigos live 2023: dr. anis hamid on where psmafore sits in mcrpc sequencing
-
4:25
uromigos live 2023: dr. pedro barata on cisplatin for bladder cancer
-
3:17
uromigos live 2023: dr. chandler park on what is still needed from psmafore
-
5:46
uromigos live 2023: dr. benjamin garmezy on new rcc data
-
43:52
uromigos live 2023: nmibc updates
-
1:30
uromigos live 2023: dr. mike morris on radioligands in prostate cancer
-
39:18
uromigos live 2023: current and future status of radioligand therapy in prostate cancer
-
25:48
the uromigos definition of oligometastatic: uromigos live 2024
-
15:37
choosing systemic therapy for men with metastatic hormone sensitive prostate cancer
-
28:33
prostate cancer highlights from esmo 2023
-
2:13
uromigos live 2023: dr. amanda nizam on her proposed trial for patients with oligometastatic uc
-
1:56
arasens: dialuramide plus adt and docetaxel for metastatic hormone-sensitive prostate cancer
-
0:47
uromigos live 2023: dr. stephanie berg on best treatment after ev/pembro for muc
-
3:13
uromigos live 2023: dr. peter o'donnell on the excitement of a new era in bladder cancer
-
3:38
breakthroughs in urothelial cancer treatment at esmo 2023
-
54:10
radioligands: uromigos live 2024
-
38:47
uromigos live 2023: where do we stand with parp inhibitors in prostate cancer?
-
4:02
dr. friedlander talks uromigos live bladder highlights
-
12:07
uromigos live 2024 front-line therapy in papillary renal cancer part 1: sunniforecast discussion
-
1:09:51
uromigos live 2023: first-line bladder cancer: what just happened?
-
3:30
uromigos live 2024 highlights: the evolving role of adt in prostate cancer